Taken together, these data strongly indicate that STC2 negatively regulates MAOB expression via an un-characterised mechanism (Fig. 8K, L), and a combined analysis of both STC2 and MAOB levels is a potential approach in assessing the prognosis of patients with HCC. This evidence concerns the gene STC2 and hepatocellular carcinoma.